Medicamen Biotech Ltd
NSE:MEDICAMEQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medicamen Biotech Ltd
NSE:MEDICAMEQ
|
IN |
|
Verra Mobility Corp
NASDAQ:VRRM
|
US |
|
NWS Holdings Ltd
HKEX:659
|
HK |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
US |
|
Gentex Corp
NASDAQ:GNTX
|
US |
|
New China Life Insurance Company Ltd
SSE:601336
|
CN |
|
G
|
Grainturk Tarim AS
IST:GRTRK.E
|
TR |
|
Calibre Mining Corp
TSX:CXB
|
CA |
|
X
|
Xinjiang Tianrun Dairy Co Ltd
SSE:600419
|
CN |
|
H
|
Hongcheng Environmental Technology Co Ltd
HKEX:2265
|
CN |
|
F
|
Filinvest REIT Corp
XPHS:FILRT
|
PH |
Bankruptcy Probability
Medicamen Biotech Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medicamen Biotech Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
M
|
Medicamen Biotech Ltd
NSE:MEDICAMEQ
|
3.2B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medicamen Biotech Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medicamen Biotech Ltd has total debt of 386.5m INR. This includes both short-term (350.3m INR) and long-term (36.2m INR) debt.
You can find a full breakdown on its Balance Sheet.
